Chloe Adrienna Talana
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, COVID-19 Clinical Research Studies, Viral gastroenteritis research and epidemiology, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants(2021)591 cited
- → Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants(2021)213 cited
- → Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529(2022)175 cited
- → Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern(2021)135 cited
- → Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+T Cells(2018)54 cited
- → Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants(2021)54 cited
- → Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability(2022)37 cited
- → Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones(2022)36 cited
- → Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants(2021)29 cited